Social SOCIAL - THE CORE OF OUR BUSINESS Social aspects are the most important ESG factor for Evotec. Our success hinges upon our peoples’ skills and dedication. This is why we especially lay our focus on training and education of our staff. Evotec strives to offer fair, respectful and attractive working conditions that allow growth for and with our people. For us, respect is deeply connected to diversity and inclusion as well as creating equity among OUR people. Furthermore, the working place we offer our people needs to be save and health-promoting. #RESEARCHNEVERSTOPS Our claim #researchneverstops will hold until effective treatments and cures have been found for every last one of more than 3,300 diseases that are undruggable today. It is therefore only natural for Evotec to pursue a strategy of very long-term, sustainable growth. Thus, addressing causes of a disease rather than only its symptoms is the driver of our daily actions. At Evotec we do research on innovative approaches to drug discovery and development for and with leading pharmaceutical and biotechnology companies as well as academic institutions. We are convinced that by uniting the different strengths of everyone we can create the best results for better medicine and for our business. That’s why we aim for long-term and strong partnerships and co-owned pipeline programmes. By connecting passionate top-class scientists, state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas we have established a unique leading position in our field. GLOBAL HEALTH Evotec makes a very important contribution to the well-being of humanity. For a large number of serious diseases there is still no cure available today and demographic change with its aging population is further increasing the need for therapies. Evotec’s stated purpose is to find new, efficacious drugs and cures that will improve the lives of millions of patients, thereby contributing to the quality of life of society as whole. Since Innovation has to be driven by the need to solve medical problems. EVT Innovate brings forward the most promising scientific ideas to make a difference in key medical research fields. Thus, Evotec is investing in first-in-class development in certain areas of high and most pressing unmet medical need, focussing mainly on mechanisms that are potentially disease modifying and not only address symptoms. The ultimate goal of EVT Innovate is to build a broad strategic pipeline, resulting in a portfolio of partnerships to ensure sustainability of these innovations. Our social responsibility efforts aim to provide access to affordable, cutting-edge drug solutions to people worldwide, regardless of their economic or social status, including settings where limited medical resources are available. OUR PEOPLE Our people matters are managed by two departments in particular. First, the Global Human Resources (HR) is an enabling function at Evotec that since 2018 reports directly to the CEO. Global HR is responsible for the company-wide people strategy, approaches, policies, processes and regulations for all people matters. Aside from the global HR team, local HR teams are established in all countries. Second, our EHS department implements measures to safeguard the health, safety and welfare of all staff and visitors, or those affected by the company’s work, so far as is reasonably practicable. As such, it is the policy of the company to provide and maintain safe and healthy working conditions, equipment and systems of work for all its staff. To this end, information, training and supervision is provided where necessary. We recognise that full compliance with all aspects of national and regional legislation relating to health and safety is essential. Nationality Split of our people as of 31/12/2020 / % Age groups of our people as of 31/12/2020 / % DIVERSITY IS KEY TO OUR SUCCESS Even though we are ONE Company, we are only as strong as we are because of the multifaceted people who drive us forward. This is the reason, why we are in regular dialogue with our people on the topic of diversity. Especially the following actions are key to tackle issues like discrimination, exclusion or racism. Make our people aware of the diversity dimensions and their meaning. Committing to Diversity as ONE company. Make our processes, internal structures and measures more diversity-friendly. Measure our progress on achieving our diversity goals. Knowledge is our Company's engine on the R&D Autobahn to Cure. On the German Diversity Day, one of our first projects we implemented, raised our peoples’ awareness on diversity topics: Now, everyone @ Evotec has the chance to test theirself in our virtual Evotec-specific Diversity quiz. Through this, we gave an idea to tackle action 1 and will continue to do so in the future as well. Related to the second action, Evotec is committed to be an inclusive employer, and we strive to reflect the diversity of the population. We believe that by embracing diversity in all its aspects, we can best nourish diversity of thought irrespective of gender, gender identity, ethnicity, sexual orientation, age, religion, disability or other characteristics. This creates the best mix of skills, talent, ideas, creativity and dedication, which makes us strong as ONE for further growth. To underline this, Evotec publicly committed itself to be an attractive and diverse employer by signing the German Diversity Charter in 2020. Our working environment is defined by respect, cooperation, openness and flexibility in the way we think and act. Whether in recruiting, staff development, promotion or pay – Evotec practices equity. In 2020, we launched a project to analyse our pay structure at the group level, including factors such as gender, seniority, performance, position level, and others. At the end of 2020, Evotec’s workforce represented 75 different nationalities (2019: 69 nationalities). With regard to gender diversity, 54.1 % of our global workforce are women. The average age of Evotec’s people at the end of 2020 was 38.8 years. 1.2% of our people have a recognised disability. These figures are the beginning to measure our development. TOP RSS Twitter LinkedIn EVOTEC @Evotec A new approach to off-the-shelf cancer vaccines - https://t.co/4Re4h5FDGx | Our latest blog details Dendritic Cells… https://t.co/xB7m0D5k8k 02:08 PM - 24 NOVEMBER 2021